Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion type Assertion NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_head.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion description "[We quantified MRD at various time points during and after therapy by real-time reverse transcriptase polymerase chain reaction (RT-PCR) for AML1/MTG8 and CBFB/MYH11 in 37 patients with CBF leukemias treated within a multicenter trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_provenance.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion evidence source_evidence_literature NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_provenance.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion SIO_000772 14645432 NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_provenance.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion wasDerivedFrom befree-2016 NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_provenance.
- NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_assertion wasGeneratedBy ECO_0000203 NP422571.RAAtlFxvusHEbAmBM4x1_6S33KuNwrK_UU69O_UsJGR7A130_provenance.